Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice

Z Wang1, Y He1, W Deng2

  • 1Georgia Cancer Center, Augusta University, Augusta, GA, USA.

Oncogene
|September 5, 2017
PubMed

Insights

Activating transcription factor 3 (ATF3) is crucial for maintaining genome stability and suppressing early cancer development. ATF3 deficiency in mice leads to spontaneous tumors and genomic instability, highlighting its role in tumor suppression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Mice lacking DNA-damage response (DDR) genes are prone to tumors due to genomic instability.
  • Activating transcription factor 3 (ATF3), a stress sensor, activates p53 and its target genes upon DNA damage.

Purpose of the Study:

  • To investigate the role of ATF3 in maintaining genome stability and suppressing tumor development.
  • To determine if ATF3 contributes to tumor suppression through p53 activation.

Main Methods:

  • Generated and analyzed Atf3-deficient (Atf3-/-) mice and wild-type (Atf3+/+) littermates.
  • Assessed chromosomal stability in Atf3-/- mouse embryonic fibroblasts (MEFs).
  • Examined tumor development in Atf3-/- mice, and in combination with Trp53+/- or Trp53-/- backgrounds.

Main Results:

  • Atf3-/- mice developed spontaneous tumors and had reduced lifespan compared to wild-type mice.
  • Atf3-/- MEFs exhibited increased chromosomal aberrations and micronuclei, indicating genetic instability.
  • ATF3 deficiency promoted p53 activation and apoptosis in mouse tissues, and its absence exacerbated tumorigenesis in Trp53+/- mice.

Conclusions:

  • ATF3 plays a critical role in maintaining genome integrity and suppressing early cancer development.
  • The tumor suppressive function of ATF3 is significantly dependent on its regulation of p53.
  • These findings establish ATF3 as a key genetic factor in preventing spontaneous tumorigenesis.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
30
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K